J. Sandberg

发表

Expansion of SARS-CoV-2–Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients

H. Ljunggren, J. Klingström, H. Asgeirsson, 2020, The Journal of Immunology.

Cell-Mediated Immune Responses and Immunopathogenesis of Human Tick-Borne Encephalitis Virus-Infection

H. Ljunggren, J. Klingström, L. Lindquist, 2018, Front. Immunol..

The Karolinska KI/K COVID‐19 immune atlas: An open resource for immunological research and educational purposes

H. Ljunggren, J. Klingström, O. Rooyackers, 2022, Scandinavian journal of immunology.

COVID‐19‐specific metabolic imprint yields insights into multiorgan system perturbations

H. Ljunggren, J. Klingström, O. Rooyackers, 2021, European journal of immunology.

Activation and Kinetics of Circulating T Follicular Helper Cells, Specific Plasmablast Response, and Development of Neutralizing Antibodies following Yellow Fever Virus Vaccination

H. Ljunggren, L. Rombo, K. Loré, 2021, The Journal of Immunology.

Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial

H. Ljunggren, J. Klingström, L. Lindquist, 2022, medRxiv.

SARS‐CoV‐2‐specific humoral and cellular immunity persists through 9 months irrespective of COVID‐19 severity at hospitalisation

H. Ljunggren, A. Sönnerborg, J. Klingström, 2021, Clinical & translational immunology.

Longitudinal characterization of humoral and cellular immunity in hospitalized COVID-19 patients reveal immune persistence up to 9 months after infection

H. Ljunggren, A. Sönnerborg, J. Klingström, 2021, bioRxiv.

Innovative vaccine approaches—a Keystone Symposia report

G. Kang, S. Madhi, G. Dougan, 2022, Annals of the New York Academy of Sciences.